Orthopedic biomaterials are synthetic or organic materials of biologic composition. Orthopedic biomaterials are commonly used in orthopedics, surgical implants, prosthetics, and various medical tools and devices. These materials are used to internally fix the fracture. Biomaterial devices are designed for various number of orthopedic applications, which are termed as ‘Implants’. The orthopedic biomaterials market involve bone graft substitutes, growth factors, orthopedic stem cells, cell therapy, hyaluronic acid visco supplementation, cartilage repair, and machined bone allografts. These materials are implanted or applied in or near the indicated bone to expedite healing, stimulate bone tissue augmentation, compensate in areas where bone tissue is depleted and restore structure to allow for repair. Various biomaterials used in orthopedic are metals or metal alloys, ceramics, tissue adhesives, polymers, carbon materials, and composites, etc. Metal is the most commonly used orthopedic material due to its properties, such as corrosion resistance, high strength, hardness, ductility, biocompatibility, and formability.
Market Dynamics
Rise in the population with musculoskeletal disorders & chronic skeletal disorders, and increasing geriatric population are some of the major factors responsible for the growth of Global Orthopedic Biomaterial Market. For instance, according to the report published by the United Nation (UN) in 2017, the global population of age 60 and above was around 962 million, and is expected to reach 2.1 billion by 2050. Among orthopedic operations, knee replacement therapy is mostly carried out in geriatrics population. Moreover, according to the Journal of Bone and Joint Surgery, by 2030 the demand for knee arthroplastics is estimated to grow by 674% during 2005 and 2030 reaching 3.48 million procedures.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook